ThyCAID

Protocol: 
AAAO2700

Thyroid Cancer and Autoimmune Diseases

Retrospective cohort study will include patients that have been diagnosed with thyroid cancer and related autoimmune diseases from 2004-2014 to evaluate incidence. 

Are you Eligible? (Inclusion Criteria)

Graves’ disease patients who have had a thyroidectomy at CUMC.

  • Hashimoto’s disease patients at CUMC
  • Systemic Autoimmune Diseases. Specific cohorts will be patients with
    1. multiple sclerosis
    2. inflammatory bowel disease
    3. systemic lupus erythematosus and
    4. rheumatoid arthritis.

Specialty Area(s)

Trial Location

Columbia University Medical Center
HIP (The Herbert Irving Pavilion)
8th Floor
New York, NY 10032
United States